ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality

Alhamed Alduihi, Fatima

doi:https://doi.org/10.1155/2021/6649572

Pulmonary Medicine

On this page

Abstract Introduction Methods Results Discussion Conclusions Data Availability Conflicts of Interest References Copyright Related Articles

Research Article | Open Access

Volume 2021 | Article ID 6649572 | https://doi.org/10.1155/2021/6649572

ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality

Fatima Alhamed Alduihi¹

Academic Editor: Yongchun Shen

Received05 Jan 2021

Revised26 Apr 2021

Accepted21 Jun 2021

Published06 Jul 2021

Abstract

Background. Bronchiectasis is an important reason for morbidity and mortality according to the last records that referred to high incidence rate of disease. Cardiovascular problems are common in pulmonary diseases, in general, and it can symptom by ECG abnormalities. The objective of this study was to define the most ECG abnormalities in patients with acute exacerbation of bronchiectasis and to study the correlation between the cardiac disorder and the other risk factors of the exacerbation. Materials and Methods. A prospective single-center observational cohort study was done at Aleppo University Hospital for patients with AEB between October 2017 and September 2018. They were divided into 2 groups (normal ECG vs. abnormal). Patients with COPD, cystic fibrosis, new diagnosis of ischemic accident through the last 6 months of the study, and treatment with macrolides or fluoroquinolones through the last 3 months of the study were excluded. We study the percent of abnormalities through the AEB and the percentage of the most common abnormalities. Results. 67 patients were included in the study (44 males and 23 females) with a mean age of . ECG abnormalities were recorded in 43 patients, and it was more common in men (67.44% of cases). Advanced age and survival state had a statistical significance (, 0.023), respectively, between the 2 groups. Right axis deviation (RAD) is the most common abnormality (23.3%) followed by sinus tachycardia (20.9%), and it is close to T-depression (18.6%). AF was the most common arrhythmia from all recorded arrhythmias (6.98% from all cases). Positive sputum cultures were recorded in 55.8%, and the most common isolated pathogen factor was Pseudomonas aeruginosa. Recurrent pneumonia was seen in 30.2% of all patients with abnormal ECG. We find a high prevalence of ECG abnormalities in patients with Oximetry (90-95%, 39.5%), and the opportunity for abnormalities is equal in the 2 age groups (45–59 and more than 75) that reflexed the possibility of cardiac disorders in any age in patients with AEB. Conclusions. ECG abnormalities are common in AEB, and it can happen in any age and any value of Oximetry. It needs more attention because of the prognosis of the cardiac morbidity.

1. Introduction

Bronchiectasis is one of the most important reasons for attending the respiratory clinics.

Recent recodes refer to higher rates of prevalence in patients from all ages, and there is a notable peak on young ages [1–4].

The heart is the organ close to the lungs from anatomic side, so it will be affected by lesions that affected the lungs like COPD and bronchiectasis. This study is aimed at evaluating the function of the heart through bronchiectasis by performing a simple procedure which is usually applied to all patients admitted to hospital (electrocardiography (ECG)).

2. Patients and Methods

2.1. Patient Population

A prospective retrospective observational one-center study was applied to patients who were admitted with the diagnosis of acute exacerbation of bronchiectasis (AEB) in the period between October 2017 and September 2018 in Aleppo University Hospital, Aleppo, Syria.

They were divided into 2 groups (normal ECG and abnormal). Patients with COPD, cystic fibrosis, long treatment or treatment through the last 3 months with macrolide or fluoroquinolones, previous diagnosis of arrhythmia, and new ischemic accident (brain or cardiac infarction) through the last 6 months were excluded.

2.2. Data Collection

We reviewed and followed the patients’ profiles and collected the following variables: demographics, smoking history, diagnosis of COPD or CF by a physician, sputum (and/or) tracheal cultures on admission, oxygen saturation on admission, medications, and morbidity.

The study is approved by the local ethical committee, and every patient agreed to continue participation in our study. Each patient gave his or her written consent for the collection and use of their clinical data.

2.3. Statistical Analysis

Demographic characteristics and variables of interest were summarized by the state of ECG (normal ECG vs. abnormal ECG) using descriptive statistics: mean (SD) for continuous variables and frequency (proportion) for categorical variables.

To assess the association between demographic characteristics and risk, logistic regression was used, and the results are reported as an odds ratio, with a 95% confidence interval.

A value of less than 0.05 was used to detect the statistical significance. is used as a test for statistical significance. Analysis was performed using IBM SPSS statistical software, V24.

3. Abbreviations Used in the Manuscript

The following abbreviations are used: ECG (electrocardiography), COPD (chronic obstructive pulmonary disease), CF (cystic fibrosis), RAD (right axis deviation), LAD (left axis deviation), LVH (left ventricle hypertrophy), HTN (hypertension), MAT (multifocal atrial tachycardia), PVC (premature ventricular complex), AEB (acute exacerbation of bronchiectasis), RBBB (right bundle-branch block), LBBB (left bundle-branch block), AF (atrial fibrillation), and AAA (acute asthma attack).

4. Results

67 patients were included in the study (44 males and 23 females) with a mean age of years old.

ECG abnormalities were recorded in 43 patients (64.17% of patients), and they were more common in men (29, 67.44% of all 43 cases).

Abnormal ECGs were recorded in patients with advanced age more than in younger ages. In a previous ischemic accident, cerebral or cardiac disorder was recorded in 20 cases (29.85%); 17 of them recorded abnormal ECGs (39.5%). Six of them have ages less than 60 years and 14 have ages more than 60 years.

Mean Oximetry (oxygen saturation) was %, and it had higher values in patients with normal ECG.

40 patients were smokers (59.7%): 12 of them have normal ECG (30% of all smokers), and 28 of them have abnormal ECG (70%).

13 patients died through one year of follow-up; only one of them has normal ECG, while 12 have abnormal ECG. The mean age of dead patients was 68.15 years: the oldest one was 99 years old, and the youngest was 15 years old.

Positive sputum cultures were recorded in 42 patients (62.68% of all cases); 24 of them (55.8%) had abnormal ECG, and 8 (33.33%) of them showed Pseudomonas aeruginosa in the result of culture, the most isolated pathogen from all the positive cultures.

Recurrent pneumonia was the most common trigger factor of exacerbation in 23 patients (34.32%). 30.2% of the patients with abnormal ECG had recurrent pneumonia.

Pleural effusions were seen only in patients with abnormal ECGs (4 patients) and also autoimmune diseases (5 cases, 4 abnormal, and 1 normal).

Bronchitis was investigated in 7 patients (10.44%); 5 of them had normal ECG, while 2 had abnormal ECG.

Increased dyspnea was a stable variant in 65 patients (97% of all patients in the study); it was seen in all patients with normal ECG and in 41 patients with abnormal ECG.

Demographic characteristics and both the likelihood ratio and value were calculated and are summarized in Table 1.

Right axis deviation (RAD) was the most common abnormality in 23.3% of cases followed by sinus tachycardia (20.9%), and it is close to T-depression (18.6%).

Both the left axis deviation (LAD) and left ventricle hypertrophy (LVH) recorded the same percent (4.7%) which reflexes the morbidity of hypertension (HTN) in such patients.

Less frequent abnormality was recorded equally for multifocal atrial tachycardia (MAT) and premature ventricular complex (PVCs) (2% for every abnormality).

Figure 1 shows the most common ECG abnormalities in patients who were included in our study with their percent of each abnormality.

What was really abnormal was a high prevalence of ECG abnormalities which was recorded in patients with oxygen saturation (90-95%, 39.5%), and the opportunity for abnormalities is equal in the 2 age groups (45–59 and more than 75), which reflexed the possibility of cardiac disorders in any age and in any value of saturation in patients with acute exacerbation of bronchiectasis (AEB).

Mortality, confirmed previous ischemic accident, and age had a statistical significance (, 0.025, and 0.003), respectively.

Figure 2 shows the graphs of the most common abnormalities according to the age.

(a)

(b)

5. Studying the Risk Estimate

To assess the association between demographic characteristics and risk of developing abnormal ECG, logistic regression was used, and the results were reported as an odds ratio, with a 95% confidence interval.

We divided patients according to age (less than 60 years and more than 60 to be more accurate regarding the age, and we did not find an important statistical significance). We also studied the oxygen saturation between 2 values (less than 92% and more than 92%).

The odds ratios for the variants are printed on Table 2.

6. Discussion

The study highlighted the fact of the correlation between bronchiectasis and ECG abnormalities, as they were found in most of the patients with a high rate of 64.17%.

Cardiac disorders are common in respiratory disease in general and especially in chronic lung diseases [5]. There were many records about the increased risk of cardiovascular diseases in patients with bronchiectasis [6, 7].

The cardiac comorbidity can be a result of the disease itself because of anatomical correlation between the lung and the heart (as in the pulmonary hypertension for example) or because of the treatment of pulmonary diseases that may affect the heart; macrolides are used widely in the treatment of community-acquired pneumonia and bronchiectasis especially in cases of long-term treatment [8–10]. The fluoroquinolone group, another drug group used widely in the treatment of bacterial exacerbations of obstructive diseases, can increase the risk of arrhythmias [11–13].

ECG is a simple procedure. It can direct the physician or clinician to misdiagnosed cardiac comorbidity in patients with bronchiectasis or any other obstructive lung disease and hypertension in patients with marks of LVH on the ECG for example.

Male gender is a risk factor for developing abnormal ECG compared with women; however, there is no important statistical significance () that refers the incidence of abnormalities as close between patients [14, 15]. Abnormal ECGs were more recorded in smokers, accepted in many studies in this field that confirmed the correlation between abnormalities and smoking [16, 17]. Mortality was higher between patients with abnormal ECGs, whose ages were advanced compared with those of young patients. This result confirmed the fact of the poor prognosis of patients with cardiac comorbidity compared with those who do not have this problem, especially in advanced ages. Age itself can be a risk factor for mortality in patients with AEB [1, 18, 19]. The likelihood ratio recorded the highest rate for age in our study (45.46). It suggested age as a reason for abnormalities by itself. It added another risk and enhanced the morbidity of the disease. Both cardiac morbidity and advanced age enhanced together the risk of mortality in such group of patients [20–22].

Oximetry (oxygen saturation) had high values in patients with normal ECG compared with those with abnormal ones, accepted in Kellett et al. [23] and Katz et al. [24], that suggested abnormalities in ECG as a result of hypoxemia in bronchoscopy, and it was so close to Romero and Jané’s study [25] that suggested hypoxia as a reason for abnormalities in ECG. In a review, there were many studies suggesting hypoxia as a reason for ECG abnormalities in patients with obstructive pulmonary diseases [26, 27].

Dyspnea was a constant symptom in all patients, and there is no statistical significance between the 2 groups of patients even though it had more risk to develop abnormalities on ECG (odds ratio, 1.585). Increased dyspnea had a likelihood of 1.808 for developing abnormal ECGs. Dyspnea can cause abnormalities in cases that lead to a metabolic acidosis [28]. Dyspnea induced by exercise in children and adolescents usually made a tachycardia, sinus, or ventricle [29, 30]. Our study showed that dyspnea was found in all patients with no differences between the 2 groups of study, normal and abnormal ECG. Nine patients with dyspnea had sinus tachycardia as the most common abnormality in the group of abnormal and also RAD.

Recurrent pneumonia triggers the exacerbation of bronchiectasis in 23 patients (34.32% of all cases, 30% of the abnormal ECG group), which confirms the etiology (postinfections) as a most common etiology in bronchiectasis [31].

Positive isolated cultures were more common in the group of abnormal ECGs, but there are no differences between the 2 groups. Pseudomonas aeruginosa was the most common isolated pathogens referred by most studies all over the world [32–35].

RAD is the most common abnormality (10 patients, 23.3%); 9 of them 90% had dyspnea.

Right bundle-branch block (RBBB) had been recorded in 9.30% (4 patients). These abnormalities correlated mainly with disorders in the function of the right ventricle that carried a specific importance to have a right catheterization for pulmonary hypertension diagnosis after echocardiography was not enough in such patients [36, 37]. Another specialty of RAD is the correlation with the cases of PCD, as it is the most ECG abnormality in patients with Kartagener disease [38–40]. Three of the patients included in the study had the diagnosis of Kartagener disease, and some had a dextrocardia and RAD on ECG.

Sinus tachycardia was recorded in 9 cases (20.9%), all of them had dyspnea, and it was very close to T-depression (8, 18.6%) which reflexed the role of infectious state on the ECG, as tachycardia is a result of infection and high temperature [41]. It carries a bad predictor of poor prognosis especially in patients with severe asthma in cases that the exacerbation of asthma was a trigger factor of the exacerbation of bronchiectasis [42]. As asthma was recorded in 6 patients (8.95% of all cases in the study), it was important to suspect a severe infection and a poor prognosis outcomes in patients with sinus tachycardia as postinfection (recurrent pneumonia), and exacerbations of asthma had a high prevalence between the patients of the study.

T wave depression is a sign of wide spectrum of cardiac and noncardiac disease [43, 44]. It can be a sign of ischemic accident (ischemic heart disease [45], pulmonary edema [46], and heart failure in athletes [47]). T wave depression had its importance because of the underlying ischemic etiology, and in our study, 6 patients of the 8 patients had a previous ischemic accident. That really confirmed the comorbidity of ischemic accidents and patients with acute exacerbation of bronchiectasis.

Hypoxia is an important reason for inversion of T wave [48]. Patients with acute respiratory alkalosis present more danger than those with chronic because they are more likely to develop metabolic compensation [49], and as a final result, a case of uncompensated acidosis can cause inversion in T wave [50, 51].

Both the left bundle-branch block (LBBB) and atrial fibrillation (AF) have a 6.98 percentage for each one. LBBB was suspected to be a risk factor for cardiovascular morbidity in patients with chronic obstructive pulmonary diseases [52], so that will be a risk factor for cardiac disorders in patients with overlap syndrome (bronchiectasis-COPD).

Atrial fibrillation was the most common recorded arrhythmia in patients with chronic pulmonary diseases, especially those associated with pulmonary hypertension [53] and COPD [54]. It was one of the important findings of the study even with excluded patients with COPD; AF is still on the top of arrhythmias in patients with acute exacerbation of bronchiectasis. Other arrhythmias were less frequent like MAT and PVCs (2.3% for each one).

A study of arrhythmias in all the included patients shows that they were recorded in only 5 cases (11.62% from all abnormalities), so it was not common in our study compared with other ECG abnormalities.

Both the left axis deviation (LAD) and left ventricle hypertrophy (LVH) had a 4.65 percentage, which is correlated with an increased high risk of hypertension comorbidity in these patients [55].

As COPD correlated with a lot of cardiac disorders [56–58] and was suspected as a risk factor for cardiovascular comorbidity in patients with emphysema [59, 60] and at last was recorded to have a high rate of arrhythmias [61, 62], it was important to exclude the patients with COPD from the study.

7. Limitations of the Study

There are a small number of patients compared with international studies, as there is no registry for bronchiectasis in Syria.

It was difficult to exclude all patients with previous ischemic accidents because of the fact that there is a high prevalence in elderly patients and those who had much comorbidity in our region.

We did not assess the severity of AEB according to faced or BSI scores because not all patients accepted had lung function diseases, and we could not depend only to the previous records; the severity of disease was assessed by advanced lesions on HRCT.

8. Strong Points

This was the first study to suggest ECG abnormalities as a predictor of cardiovascular morbidity in patients with acute exacerbation of bronchiectasis. Patients of COPD were excluded to be more accurate and definite to bronchiectasis without overlap syndrome with COPD.

9. Conclusions

ECG abnormalities are common in patients with acute exacerbation of bronchiectasis. It can happen in any age and any value of oxygen saturation (Oximetry). Advanced age and survival state had a statistical significance ( and 0.023), respectively, between the 2 groups.

Male gender, smoking, and increasing dyspnea are factors with more likely opportunity for developing abnormalities on ECG.

Data Availability

The data are available from the corresponding author on a reasonable request.

Conflicts of Interest

There are no conflicts of interest.

References

F. A. Alduihi and A. Khoury, “Factors affecting readmitted patients with acute exacerbation of bronchiectasis,” The Egyptian Journal of Internal Medicine, vol. 31, no. 4, pp. 779–782, 2019.
View at: Publisher Site | Google Scholar
A. Khoury and F. A. Alduihi, “O'Donnell criteria as a sign of bad prognosis in hospitalized patients with bronchiectasis,” Journal of the Arab Board of Health Specializations, vol. 3, 2019.
View at: Google Scholar
M. Loeve, K. Gerbrands, W. C. Hop, M. Rosenfeld, I. C. Hartmann, and H. A. Tiddens, “Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis,” Chest, vol. 140, no. 1, pp. 178–185, 2011.
View at: Publisher Site | Google Scholar
S. Ginde and M. G. Earing, “When the heart is not to blame: managing lung disease in adult congenital heart disease,” Progress in cardiovascular diseases, vol. 61, no. 3-4, pp. 314–319, 2018.
View at: Publisher Site | Google Scholar
C. Jenkins, “Cardiovascular comorbidity in chronic lung disease: gender differences,” in Cardiac Considerations in Chronic Lung Disease, pp. 25–43, Springer International Publishing, 2020.
View at: Publisher Site | Google Scholar
A. D. Saleh, B. Kwok, J. S. Brown, and J. R. Hurst, “Correlates and assessment of excess cardiovascular risk in bronchiectasis,” European Respiratory Journal, vol. 50, no. 5, p. 1701127, 2017.
View at: Publisher Site | Google Scholar
S. Chen, A. Qiu, Z. Tao, and H. Zhang, “Clinical impact of cardiovascular disease on patients with bronchiectasis,” BMC Pulmonary Medicine, vol. 20, no. 1, 2020.
View at: Publisher Site | Google Scholar
J. D. Chalmers, W. Boersma, M. Lonergan et al., “Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis,” The Lancet Respiratory Medicine, vol. 7, no. 10, pp. 845–854, 2019.
View at: Publisher Site | Google Scholar
C. Kelly, D. J. Evans, J. D. Chalmers et al., “Macrolide antibiotics for non-cystic fibrosis bronchiectasis,” The Cochrane Database of Systematic Reviews, vol. 10, 2016.
View at: Publisher Site | Google Scholar
D. Wang, W. Fu, and J. Dai, “Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis,” Medicine, vol. 98, no. 17, 2019.
View at: Publisher Site | Google Scholar
X. Liu, J. Ma, L. Huang et al., “Fluoroquinolones increase the risk of serious arrhythmias: a systematic review and meta-analysis,” Medicine, vol. 96, no. 44, 2017.
View at: Publisher Site | Google Scholar
L. A. Polgreen, B. N. Riedle, J. E. Cavanaugh et al., “Estimated cardiac risk associated with macrolides and fluoroquinolones decreases substantially when adjusting for patient characteristics and comorbidities,” Journal of the American Heart Association, vol. 7, no. 9, 2018.
View at: Publisher Site | Google Scholar
F. Amati, M. Di Pasquale, M. I. Restrepo, J. Marin-Corral, S. Aliberti, and F. Blasi, “Cardiovascular side-effects of common antibiotics,” in Cardiovascular Complications of Respiratory Disorders (ERS Monograph), M. A. Martínez-García, J. L. Pépin, and M. Cazzola, Eds., pp. 264–278, European Respiratory Society, Sheffield, 2020.
View at: Google Scholar
M. P. Czubryt, L. Espira, L. Lamoureux, and B. Abrenica, “The role of sex in cardiac function and disease,” Canadian journal of physiology and pharmacology, vol. 84, no. 1, pp. 93–109, 2006.
View at: Publisher Site | Google Scholar
H. T. Shih, C. R. Webb, W. A. Conway, E. Peterson, B. Tilley, and S. Goldstein, “Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease,” Chest, vol. 94, no. 1, pp. 44–48, 1988.
View at: Publisher Site | Google Scholar
N. K. Sharma, K. K. Jaiswal, S. R. Meena et al., “ECG changes in young healthy smokers: a simple and cost-effective method to assess cardiovascular risk according to pack-years of smoking,” Journal of The Association of Physicians of India, vol. 65, 2017.
View at: Google Scholar
D. Domala Prasad, A. Berad, and T. V. Sagar, “Study of ECG changes in smokers compared to non smokers,” Scholars International Journal of Anatomy and Physiology, vol. 2, no. 1, pp. 37–40, 2019.
View at: Google Scholar
J. D. Finklea, G. Khan, S. Thomas, J. Song, D. Myers, and A. C. Arroliga, “Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis,” Respiratory Medicine, vol. 104, no. 6, pp. 816–821, 2010.
View at: Publisher Site | Google Scholar
F. A. Alduihi and A. Khoury, “Mario warning sign for mortality in acute exacerbation of bronchiectasis,” European respiratory and pulmonary diseases, vol. 5, no. 1, pp. 20-21, 2019.
View at: Google Scholar
M. J. McDonnell, S. Aliberti, P. C. Goeminne et al., “Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study,” The lancet Respiratory medicine, vol. 4, no. 12, pp. 969–979, 2016.
View at: Publisher Site | Google Scholar
W. J. Guan, Y. H. Gao, D. de la Rosa-Carrillo, and M. Á. Martínez-García, “Cardiovascular implications in bronchiectasis,” Cardiovascular Complications of Respiratory Diseases, vol. 88, p. 96, 2020.
View at: Google Scholar
V. Navaratnam, A. A. Root, I. Douglas, L. Smeeth, R. B. Hubbard, and J. K. Quint, “Cardiovascular outcomes after a respiratory tract infection among adults with non–cystic fibrosis bronchiectasis: a general population–based study,” Annals of the American Thoracic Society, vol. 15, no. 3, pp. 315–321, 2018.
View at: Publisher Site | Google Scholar
J. Kellett, B. Deane, and M. Gleeson, “Derivation and validation of a score based on Hypotension, Oxygen saturation, low Temperature, ECG changes and Loss of independence (HOTEL) that predicts early mortality between 15 min and 24 h after admission to an acute medical unit,” Resuscitation, vol. 78, no. 1, pp. 52–58, 2008.
View at: Publisher Site | Google Scholar
A. S. Katz, E. L. Michelson, J. Stawicki, and F. D. Holford, “Cardiac arrhythmias frequency during fiberoptic bronchoscopy and correlation with hypoxemia,” Archives of internal medicine, vol. 141, no. 5, pp. 603–606, 1981.
View at: Publisher Site | Google Scholar
D. Romero and R. Jané, “Hypoxia-induced effects on ECG depolarization by time warping analysis during recurrent obstructive apnea,” in 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), pp. 2626–2629, Montreal, QC, Canada, 2020.
View at: Publisher Site | Google Scholar
Gong H Jr, D. P. Tashkin, E. Y. Lee, and M. S. Simmons, “Hypoxia-altitude simulation test: evaluation of patients with chronic airway obstruction,” American Review of Respiratory Disease, vol. 130, no. 6, pp. 980–986, 1984.
View at: Publisher Site | Google Scholar
K. G. Rosen and I. Kjellmer, “Changes in the fetal heart rate and ECG during hypoxia,” Acta Physiologica Scandinavica, vol. 93, no. 1, pp. 59–66, 1975.
View at: Publisher Site | Google Scholar
A. S. Olson, A. Messersmith, and M. Robinson, “The patient with dyspnea,” Electrocardiogram in Clinical Medicine, vol. 5, pp. 219–228, 2020.
View at: Google Scholar
R. Bhatia, M. Abu-Hasan, and M. Weinberger, “Exercise-induced dyspnea in children and adolescents: differential diagnosis,” Pediatric annals, vol. 48, no. 3, pp. e121–e127, 2019.
View at: Publisher Site | Google Scholar
B. Kessen and K. Williamson, “The ECG in clinical medicine,” Electrocardiogram in Clinical Medicine, vol. 5, 2020.
View at: Publisher Site | Google Scholar
M. A. Martinez-García, C. Villa, Y. Dobarganes et al., “RIBRON: the Spanish online bronchiectasis registry. Characterization of the first 1912 patients,” Archivos de Bronconeumología (English Edition), vol. 57, no. 1, pp. 28–35, 2021.
View at: Publisher Site | Google Scholar
K. Dimakou, C. Triantafillidou, M. Toumbis, K. Tsikritsaki, K. Malagari, and P. Bakakos, “Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients,” Respiratory Medicine, vol. 116, pp. 1–7, 2016.
View at: Publisher Site | Google Scholar
R. Dhar, S. Singh, D. Talwar et al., “Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry,” The Lancet Global Health, vol. 7, no. 9, pp. e1269–e1279, 2019.
View at: Publisher Site | Google Scholar
S. K. Visser, P. T. Bye, G. J. Fox et al., “Australian adults with bronchiectasis: the first report from the Australian Bronchiectasis Registry,” Respiratory Medicine, vol. 155, pp. 97–103, 2019.
View at: Publisher Site | Google Scholar
J. Rademacher, F. C. Ringshausen, H. Suhling et al., “Lung transplantation for non-cystic fibrosis bronchiectasis,” Respiratory Medicine, vol. 115, pp. 60–65, 2016.
View at: Publisher Site | Google Scholar
G. Kovacs, A. Avian, V. Foris et al., “Use of ECG and other simple non-invasive tools to assess pulmonary hypertension,” PLoS One, vol. 11, no. 12, article e0168706, 2016.
View at: Publisher Site | Google Scholar
S. Igata, N. Tahara, Y. Sugiyama et al., “Utility of the amplitude of RV1+ SV5/6 in assessment of pulmonary hypertension,” PLoS One, vol. 13, no. 11, article e0206856, 2018.
View at: Publisher Site | Google Scholar
B. Ghewade, S. Cladius, S. Chaudhari, and A. Bhake, “A case of Kartagener syndrome with pulmonary hypertension,” Journal of Medical Cases, vol. 7, no. 8, pp. 326–330, 2016.
View at: Publisher Site | Google Scholar
T. Martínez-Fernández, Y. Rivera-Sánchez, and P. Sharma, “Pulmonology,” in Pediatric Board Study Guide: A Last Minute Review, pp. 691–730, Springer, 2020.
View at: Publisher Site | Google Scholar
V. Selvaraj, “Kartageners syndrome,” University Journal of Medicine and Medical Specialities, vol. 2, 2017.
View at: Google Scholar
S. A. Shabtaie, C. M. Witt, and S. J. Asirvatham, “Natural history and clinical outcomes of inappropriate sinus tachycardia,” Journal of cardiovascular electrophysiology, vol. 31, no. 1, pp. 137–143, 2020.
View at: Publisher Site | Google Scholar
A. A. Mohammed and H. K. Salih, “A study of electrocardiographic changes in asthmatic patients attending Kirkuk General Hospital,” Journal of Kirkuk Medical College, vol. 6, no. 1, p. 18, 2018.
View at: Google Scholar
A. K. Bhoi, K. S. Sherpa, B. Khandelwal, and P. K. Mallick, “T wave analysis: potential marker of arrhythmia and ischemia detection-a review,” in Cognitive Informatics and Soft Computing: Proceeding of CISC 2017, pp. 121–130, Springer, 2019.
View at: Publisher Site | Google Scholar
A. Cardona, K. M. Zareba, H. N. Nagaraja et al., “T-wave abnormality as electrocardiographic signature of myocardial edema in non-ST-elevation acute coronary syndromes,” Journal of the American Heart Association, vol. 7, no. 3, 2018.
View at: Publisher Site | Google Scholar
D. J. Dzikowicz and M. G. Carey, “Cardiac cases. Myocardial ischemic induced non-sustained ventricular tachycardia in an older adult with pneumonia,” Medsurg Nursing, vol. 29, 2020.
View at: Google Scholar
T. M. Reed, “Immersion pulmonary edema in the setting of Takotsubo cardiomyopathy,” International Cardiovascular Forum Journal, vol. 5, 2016.
View at: Publisher Site | Google Scholar
D. Akdis, C. Brunckhorst, F. Duru, Department of Cardiology, University Heart Center, Zurich, Switzerland, Center for Integrative Human Physiology, University of Zurich, Switzerland, and A. M. Saguner, “Arrhythmogenic cardiomyopathy: electrical and structural phenotypes,” Arrhythmia & electrophysiology review, vol. 5, no. 2, pp. 90–101, 2016.
View at: Publisher Site | Google Scholar
D. A. Monteiro, E. W. Taylor, D. J. McKenzie, F. T. Rantin, and A. L. Kalinin, “Interactive effects of mercury exposure and hypoxia on ECG patterns in two neotropical freshwater fish species: matrinxã, Brycon amazonicus and traíra, Hoplias malabaricus,” Ecotoxicology, vol. 29, no. 4, pp. 375–388, 2020.
View at: Publisher Site | Google Scholar
R. A. Johnson, “A quick reference on respiratory alkalosis,” Veterinary Clinics: Small Animal Practice, vol. 47, no. 2, pp. 181–184, 2017.
View at: Publisher Site | Google Scholar
G. F. Glass, A. Sudhir, and A. A. Pandit, “The ECG and metabolic abnormalities,” Electrocardiogram in Clinical Medicine, vol. 5, pp. 307–313, 2020.
View at: Publisher Site | Google Scholar
E. Barkoudah and C. L. Roy, “The many shades of dyspnea,” The American journal of medicine, vol. 131, no. 1, pp. e5–e6, 2018.
View at: Publisher Site | Google Scholar
B. Lazović, N. Jovičić, V. Radlović et al., “Electrocardiographic predictors of five years mortality in chronic obstructive pulmonary disease patients,” Srpski arhiv za celokupno lekarstvo, vol. 149, 2021.
View at: Publisher Site | Google Scholar
C. A. Vahdatpour, J. J. Luebbert, and H. I. Palevsky, “Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension,” Pulmonary Circulation, vol. 10, no. 1, p. 204589402091068, 2020.
View at: Publisher Site | Google Scholar
K. Milne and D. D. Sin, “Acute exacerbations of chronic lung disease: cardiac considerations,” in Cardiac Considerations in Chronic Lung Disease, pp. 229–245, Springer International Publishing, 2020.
View at: Publisher Site | Google Scholar
X. Yu, Y. Xue, B. Bian et al., “NLR-A simple indicator of inflammation for the diagnosis of left ventricular hypertrophy in patients with hypertension,” International Heart Journal, vol. 61, no. 2, pp. 373–379, 2020.
View at: Publisher Site | Google Scholar
P. Rogliani, B. L. Ritondo, R. Laitano, A. Chetta, and L. Calzetta, “Advances in understanding of mechanisms related to increased cardiovascular risk in COPD,” Expert Review of Respiratory Medicine, vol. 15, no. 1, pp. 59–70, 2021.
View at: Publisher Site | Google Scholar
M. Shnoda, K. Gajjar, and V. Ivanova, “COPD and cardiovascular disease: a review of association, interrelationship, and basic principles for integrated management,” Critical Care Nursing Quarterly, vol. 44, no. 1, pp. 91–102, 2021.
View at: Publisher Site | Google Scholar
D. A. McAllister, J. D. Maclay, N. L. Mills et al., “Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD,” European Respiratory Journal, vol. 39, no. 5, pp. 1097–1103, 2012.
View at: Publisher Site | Google Scholar
H. Müllerova, A. Agusti, S. Erqou, and D. W. Mapel, “Cardiovascular comorbidity in COPD: systematic literature review,” Chest, vol. 144, no. 4, pp. 1163–1178, 2013.
View at: Publisher Site | Google Scholar
K. Onishi, “Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease,” Journal of Cardiology, vol. 70, no. 2, pp. 128–134, 2017.
View at: Publisher Site | Google Scholar
T. Rusinowicz, T. M. Zielonka, and K. Zycinska, “Cardiac arrhythmias in patients with exacerbation of COPD,” in Clinical Management of Pulmonary Disorders and Diseases, pp. 53–62, Springer, 2017.
View at: Publisher Site | Google Scholar
T. Konecny, J. Y. Park, K. R. Somers et al., “Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias,” The American journal of cardiology, vol. 114, no. 2, pp. 272–277, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Fatima Alhamed Alduihi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2552

Downloads

1411

Citations